CASE REPORT

Exchange transfusion in initial phase of acute encephalopathy bilirubin of a 7-day old neonate: a case report

Ni Komang Diah Saputri , Made Kardana

Ni Komang Diah Saputri
. Email: diah_saputri@yahoo.com

Made Kardana

Online First: July 16, 2018 | Cite this Article
Diah Saputri, N., Kardana, M. 2018. Exchange transfusion in initial phase of acute encephalopathy bilirubin of a 7-day old neonate: a case report. Medicina 49(2). DOI:10.15562/medicina.v49i2.122


Hyperbilirubinemia is a common problem in neonatal period, occurring in 60-70% of term and 80% of preterm infants in the first week of life. The elevation of free unconjugated bilirubin can enter the central nervous system which is noxious to neuron and increase the risk of acute bilirubin encephalopathy (ABE). Risk factors of encephalopathy bilirubin or kernicterus with hemolytic disease such as ABO or Rhesus haemolytic disease, G6PD deficiency. The incidence of ABE is about 0.9/100 000. Clinically bilirubin encephalopathy can be devided into 2 phase, acute and chronic phase. The initial of acute phase is noted by lethargy, hypotonia, decreased movement and poor suck, the symptoms will get worsen if the baby doesn’t get adequte therapy. The main of management ABE is exchange transfusion and continues phototherapy to reduce bilirubin level and prevent further hemolysis.

We report a case of exchange transfusion in initial phase of acute encephalopathy bilirubin in a 7-day old neonate with ABO incompatibility, whom had icterus since the first day of life. Other complaints are poor feeding, lethargy and hoarsness of cry since one day before admitted to hospital. He was born from mother with O blood type and positive rhesus. The patient had B blood type with positive rhesus, coomb test was positive and the total bilirubin was 41.49 mg/dL, direct bilirubin was 2.8 mg/dl and indirect bilirubin was 38.69 mg/dL. The patient was treated with exchange transfusion, intensive phototherapy.

 

 

References

Gomella TL, Cunningham MD, Eyal FG. Hyperbilirubinemia, Indirect (Unconjugated Hyperbilirubinemia). Neonatology: management, procedures, on-call problems, diseases, and drugs. Lange. McGraw Hill-USA. 2013;30:408-508.

Jardine LA, Woodgate P. Neonatal jaundice. BMJ. 2011;09:319.

NICE. Neonatal jaundice. National collaborating center for women’s and Children’s health. Clinical guideline, 2010.

Whitehurst Jr. RM. ABO incompatibility. Neonatology Management, Procedures, On-call Problems, Diseases, and Drugs 7th ed. Lange. McGraw-Hill–USA. 2013;80:547-9.

Mentzer WC, Glader BE. ABO incompatibility. Avery’s Disease of The Newborn 8th ed. Elsevier. 2005;77:1191-2.

Allen NM et al. Severe hyperbilirubinaemia and kernicterus: more caution is needed in newborn jaundice surveillance. Irish Medical Journal, 2009;102:228–229.

Heydarian F, Majdi M. Severe neonatal hyperbilirubinemia; causes and contributing factors leading to exchange transfusion at Ghaem Hospital in Mashhad. Acta Medica Iranica. 2010;48:399-402.

Esfandiarpour B, Ebrahimi H, Karkan MF, Farahmand N, Karambin MM. Neonatal exchange transfusion for hyperbilirubinemia in Guilan (the north province of Iran): a 3-Year Experience. The Turkish Journal of Pediatrics. 2012:54:626-31.

Usman Ali. Ensefalopati Bilirubin. Sari Pediatri. 2007;8:94-104.

Sakha SH, Gharehbaghi MM. Exchange transfusion in severe hyperbilirubinemia: an experience in Northwest Iran. The Turkish Journal of Pediatrics. 2010;52:367-71.

Behjati SH, Sagheb S, Aryasepehr S, Yaghmai B. Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia. Indian Jour of Ped. 2009;76:83-5.

American Academy of Pediatrics Subcommittee on hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.

Bjerre JV, Petersen JR, Ebbesen F. Surveillance of extreme hyperbilirubinemia in Denmark. A method to identity the new born infants. Acta Paediatr 2008;97:1030-4.

Watchko JF, Tiribelli C. Bilirubin-Induced Neurologic Damage Mechanism and Management Approaches. The New England Journal of Medicine. 2013;369:2034-43.

Shapiro SM. Bilirubin Toxicity in Developing Nervous System. Pediatr N Eurol 2003;29:410-21.

Whitehurst Jr. RM. ABO incompatibility. Neonatology Management, Procedures, On-call Problems, Diseases, and Drugs 7th ed. Lange. McGraw-Hill – USA. 2013;80:547-9.

Rasul CH, Hasan A, Farhana Y. Outcome of Neonatal Hyperbilirubinemia in a Tertiary Care Hospital in Bangladesh. Malaysian J Med Sci. 2010;17:40-4

Al Swaf FB, Jumaa RS, Saeed IS. Hemolytic disease of newborn due to ABO incompatibility. Tikrit Medical Journal. 2009;145:70-8.

Jardine LA, Woodgate P. Neonatal jaundice. BMJ. 2011;09:319.

Gomella TL, Cunningham MD, Eyal FG. Exchange transfusion. Neonatology: management, procedures, on-call problems, diseases, and drugs. Lange. McGraw Hill-USA. 2013;30:267-271.

Dharmesh C S, Sunita R, Sudha I, Bharat J, Satya S, Ajay G, Rahul S. Efficacy of Whole Blood Reconstituted (WBR) in Exchange Transfusion (ET) in Hemolytic Disease of New Born (HDN) — A Study of 110 Cases. Journal of Blood Diseases. 2013;3:15-20.

Sabzehei MK, Basiri B, Shokouhi M, dan Torabian S. Complications of exchange transfusion in hospitalized neonates in two neonatal centers in Hamadan, A five-year experience. Journal of Comprehensive Pediatrics. 2015;6:e205872.

Iskander I, Gamaleldin R, Houchi SE, Shenawy AE, Seound I, Gharbawi NE, et al. Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy. Journal of Pediatrics. 2014;134:e1330–9.

Martinez-Cruz, Themann PG, Poblano A, dan Cedilo-Rodriguez. Hearing and neurological impairment in children with history of exchange transfusion for neonatal hyperbilirubinemia. International Journal of Pediatric 2014;17:1-7.


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0